Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 75 | 0 | 13 | 0 | €820.80 | €831.01 | 1.244% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 2 | 0 | €428.05 | €450.36 | 5.213% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,028.5 | €1,087.6 | 5.742% |
| Insmed Inc. | 46 | 0 | 2 | 0 | €65.50 | €77.15 | 17.786% |
| Alnylam Pharmace. | 44 | 0 | 4 | 0 | €244.00 | €275.35 | 12.850% |
| Neurocrine Bioscience | 42 | 0 | 5 | 0 | €108.00 | €155.89 | 44.343% |
| Johnson & Johnson | 40 | 1 | 4 | 0 | €149.26 | €193.85 | 29.877% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.72 | €29.92 | 103.299% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 5 | 0 | €68.00 | €85.00 | 25.000% |
| AbbVie Inc. | 34 | 0 | 1 | 0 | €173.86 | €180.90 | 4.051% |
| Cytokinetics Inc. | 35 | 1 | 5 | 0 | €50.00 | €83.13 | 66.263% |
| Jazz Pharmaceuticals plc | 32 | 0 | 3 | 0 | €98.66 | €183.41 | 85.906% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €107.00 | €126.38 | 18.112% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | €64.44 | €100.74 | 56.328% |
| United Therapeutics | 28 | 1 | 3 | 0 | €308.40 | €315.21 | 2.208% |
| Ultragenyx Pharmaceutical Inc. | 28 | 1 | 3 | 0 | €51.50 | €84.74 | 64.551% |
| Amgen Inc. | 27 | 0 | 0 | 0 | €301.30 | €304.82 | 1.168% |
| Pfizer Inc. | 30 | 4 | 6 | 0 | €26.76 | €40.68 | 52.063% |
| Icon plc | 25 | 0 | 3 | 0 | €263.10 | €328.02 | 24.675% |
| Trinity Biotech ADR | 25 | 0 | 2 | 0 | €0.41 | - | - |
| Novo Nordisk A/S ADR | 26 | 1 | 5 | 0 | €121.00 | €144.83 | 19.696% |
| Halozyme Therapeutics Inc. | 24 | 0 | 3 | 0 | €54.70 | €58.12 | 6.254% |
| Exelixis Inc. | 22 | 0 | 2 | 0 | €24.15 | €26.01 | 7.687% |
| Zoetis Inc. A | 23 | 1 | 2 | 0 | €177.46 | €196.17 | 10.541% |
| Sutro Biopharma Inc | 21 | 0 | 1 | 0 | €3.52 | €10.89 | 209.375% |